CellSeal References
Journal Articles
September 2024 | CellSeal® References | Journal Articles
Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First‑in‑Human Study with Minimum 6 Months Follow‑up
Authors: M.H., J., Bozyk, Niezgoda, K., Heydemann, A., Tullius, A., Siemionow, K., S.G., Bieganski, Ziemiecka, Siemionow, G., A., M., Wachowiak, Sikorska, Czarnota
Published: Stem Cell Reviews and Reports, 2023